<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>AIMS/HYPOTHESIS: Type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> is not only associated with <z:e sem="disease" ids="C0020456" disease_type="Disease or Syndrome" abbrv="">hyperglycaemia</z:e>, but also with disorders of <z:chebi fb="23" ids="18059">lipid</z:chebi> metabolism </plain></SENT>
<SENT sid="1" pm="."><plain>The aim of this study was to investigate the association of <z:chebi fb="0" ids="17855">triglyceride</z:chebi> and non-<z:chebi fb="4" ids="47775">HDL-cholesterol</z:chebi> concentrations with <z:e sem="disease" ids="C0007222" disease_type="Disease or Syndrome" abbrv="CVD">cardiovascular disease</z:e> in subjects with <z:mpath ids='MPATH_458'>normal</z:mpath> and abnormal <z:chebi fb="105" ids="17234">glucose</z:chebi> metabolism </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: Subjects were 869 men and 948 women aged 50 to 75 who participated in the Hoorn Study, a population-based cohort study that started in 1989 </plain></SENT>
<SENT sid="3" pm="."><plain><z:chebi fb="105" ids="17234">Glucose</z:chebi> metabolism was determined by a 75 g OGTT </plain></SENT>
<SENT sid="4" pm="."><plain>High fasting <z:chebi fb="0" ids="17855">triglyceride</z:chebi> and non-<z:chebi fb="4" ids="47775">HDL-cholesterol</z:chebi> concentrations were defined as above the median of the study population </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: After 10 years of follow-up, the age- and sex-adjusted hazard ratios for <z:e sem="disease" ids="C0007222" disease_type="Disease or Syndrome" abbrv="CVD">cardiovascular disease</z:e> were 1.35 (1.11-1.64) and 1.71 (1.40-2.08) for high <z:chebi fb="4" ids="17855">triglycerides</z:chebi> and high non-<z:chebi fb="4" ids="47775">HDL-cholesterol</z:chebi>, respectively, after mutual adjustment </plain></SENT>
<SENT sid="6" pm="."><plain>After stratification for <z:chebi fb="105" ids="17234">glucose</z:chebi> metabolism status, the hazard ratios for <z:e sem="disease" ids="C0007222" disease_type="Disease or Syndrome" abbrv="CVD">cardiovascular disease</z:e> for non-<z:chebi fb="4" ids="47775">HDL-cholesterol</z:chebi> were 1.70 (1.31-2.21) in <z:mpath ids='MPATH_458'>normal</z:mpath> <z:chebi fb="105" ids="17234">glucose</z:chebi> metabolism and 1.56 (1.12-2.18) in abnormal <z:chebi fb="105" ids="17234">glucose</z:chebi> metabolism </plain></SENT>
<SENT sid="7" pm="."><plain><z:chebi fb="4" ids="17855">Triglycerides</z:chebi> were not a risk factor in subjects with <z:mpath ids='MPATH_458'>normal</z:mpath> <z:chebi fb="105" ids="17234">glucose</z:chebi> metabolism, with a hazard ratio of 0.94 (0.73-1.22), but in subjects with abnormal <z:chebi fb="105" ids="17234">glucose</z:chebi> metabolism, the hazard ratio for <z:e sem="disease" ids="C0007222" disease_type="Disease or Syndrome" abbrv="CVD">cardiovascular disease</z:e> was 1.54 (1.07-2.22) </plain></SENT>
<SENT sid="8" pm="."><plain>In subjects with abnormal <z:chebi fb="105" ids="17234">glucose</z:chebi> metabolism, the hazard ratio for the combined presence of high <z:chebi fb="4" ids="17855">triglycerides</z:chebi> and non-<z:chebi fb="4" ids="47775">HDL-cholesterol</z:chebi> was 2.12 (1.35-3.34) </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSION: Our data suggest that in people with abnormal <z:chebi fb="105" ids="17234">glucose</z:chebi> metabolism, but not in those with <z:mpath ids='MPATH_458'>normal</z:mpath> <z:chebi fb="105" ids="17234">glucose</z:chebi> metabolism, high <z:chebi fb="0" ids="17855">triglyceride</z:chebi> concentration could be associated with the risk of <z:e sem="disease" ids="C0007222" disease_type="Disease or Syndrome" abbrv="CVD">cardiovascular disease</z:e>, particularly in people with high non-<z:chebi fb="4" ids="47775">HDL-cholesterol</z:chebi> </plain></SENT>
</text></document>